The OX-40 receptor provides a potent co-stimulatory signal capable of inducing encephalitogenicity in myelin-specific CD4+ T cells

International Immunology

Volumn 10, Issue 4, 1998, Pages 453-461

  Kaleeba, J A R ^a   Offner, H ^a,b   Vandenbark, A A ^a,b   Lublinski, A ^c   Weinberg, A D ^a,c  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b PORTLAND VA MEDICAL CENTER   (United States)

^c PROVIDENCE PORTLAND MEDICAL CENTER   (United States)

Author keywords

CD4+ T cells; Co stimulation; Experimental autoimmune encephalomyelitis

Indexed keywords

CD28 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; MESSENGER RNA; MYELIN BASIC PROTEIN; T LYMPHOCYTE RECEPTOR;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; LYMPHOCYTE ACTIVATION; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ANTIGENS, CD27; ANTIGENS, CD28; ANTIGENS, CD80; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; EPITOPES; LYMPHOCYTE ACTIVATION; MYELIN BASIC PROTEINS; RATS; RATS, INBRED LEW; RECEPTORS, IMMUNOLOGIC; RECEPTORS, OX40; RECEPTORS, TUMOR NECROSIS FACTOR; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 0031944922     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/10.4.453     Document Type: Article

References (44)

1. Lenschow, D. J., Walunas, T. L. and Bluestone, J. A. 1996. CD28/ B7 system of T cell co-stimulation. Ann. Rev. Immunol. 14:233.
2. Krummel, M. F. and Allison, J. P. 1996. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J. Exp. Med. 183:2533.
3. Walunas, T. L., Bakker, C. Y. and Bluestone, J. A. 1996. CTLA-4 ligation blocks CD28-dependent T cell activation. J. Exp. Med. 183:2541.
4. van Seventer, G. A., Newman, W., Shimizu, Y., Nutman, T. B., Tanaka, Y., Horgan, K. J., Gopal, T. V., Ennis, E., O'Sullivan, D., Grey, H. and Shaw, S. 1991. Analysis of T cell stimulation by superantigen plus major histocompatibility complex class II molecules or by CD3 monoclonal antibody: co-stimulation by purified adhesion ligands VCAM-1, ICAM-1, but not ELAM-1. J. Exp. Med. 174:901.
5. + T lymphocytes. J. Immunol. 148:1985.
6. Liu, Y., Jones, B. Brady, W. Janeway, C. A., Jr and Linsley, P. S. 1992. Co-stimulation of murine CD4 T cell growth: cooperation between B7 and heat-stable antigen. Eur. J. Immunol. 22:2855.
7. Janeway, C. A., Jr and Bottomly, K. 1994. Signals and signs for lymphocyte responses. Cell 76:275.
8. Paterson, D. J., Jefferies, W. A., Green, J. R., Brandon, M. R., Corthesy, P., Puklavec, M. and Williams, A. F. 1987. Antigens of activated rat T lymphocytes including a molecule of 50,000 Mr detected only on CD4 positive T blasts. Mol. Immunol. 24:1281.
9. Hintzen, R. Q., de Jong, R., Lens, S. M. A. and van Lier, R. A. W. 1994. CD27: marker and mediator of T-cell activation? Immunol. Today 15:307.
10. Mallett, S., Fossum, S. and Barclay, A. N. 1990. Characterization of the MRC OX-40 antigen of activated CD4 positive T lymphocytes-a molecule related to nerve growth factor receptor. EMBO J. 9:1063.
11. Callard, R., Armitage, R. J., Fanslow, W. C. and Spriggs, M. K. 1993. CD40 ligand and its role in X-linked hyper-IgM syndrome. Immunol. Today 14:559.
12. Mayawaki, T., Uehara, T., Nibu, R., Tsuji, T., Yachie, A., Yonehara, S. and Taniguchi, N. 1992. Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood. J. Immunol. 149:3753.
13. Watanabe-Fukunaga, R., Brannan, C. I., Copeland, N. G., Jenkins, N. A. and Nagata, S. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314.
14. Calderhead, D. M., Buhlman, J. E., van den Eertwegh, A. J. M., Claassen, E., Noelle, R. J. and Fell, H. P. 1993. Cloning of mouse OX40: a T cell activation marker that may mediate T-B cell interactions. J. Immunol. 151:5261.
15. Latza, U., Durkop, H., Schnittger, S., Eitelbach, F., Hummel, M., Fonatcsh, C. and Stein, H. 1994. The human OX40 homolog: cDNA structure, expression and chromosomal assignment of the ACT35 antigen. Eur. J. Immunol. 24:677.
16. Weinberg, A. D., Wallin, J. J. Jones, R. E. Sullivan, T. J. Bourdette, D. N. Vandenbark, A. A. and Offner, H. 1994. Target organ specific upregulation of the MRC OX-40 marker and selective production of Th1 lymphokine mRNA by encephalitogenic T helper cells isolated from the spinal cord of rats with experimental autoimmune encephalomyelitis. J. Immunol. 152:4712.
17. Weinberg, A. D., Sullivan, T. J., Lemon, M., Wallin, J. J., Bourdette, D. N., Harmon, R. C., Fulton, R. J., Offner, H. and Vandenbark, A. A. 1996. Selective depletion of myelin-reactive T cells with the anti-OX-40 antibody ameliorates autoimmune encephalomyelitis. Nat. Med. 2:183.
18. Tittle, T. V., Weinberg, A. D. Steinkeler, C. N. and Maziarz, R. T. 1997. Expression of the T-cell activation antigen, OX-40, identifies alloreactive T cells in acute graft-versus-host disease. Blood. 8:4652.
19. + draining lymph node cells isolated from patients with melanoma and head and neck cancer. Am. J. Surg. 174:258.
20. + spinal cord T cells of Lewis rats with EAE. J. Neurosci. Res. 44:562,
21. + T cells within the spinal cord of Lewis rats with autoimmune encephalomyelitis. J. Neurosci. Res. 43:42.
22. β genes in rats with EAE. J. Immunol. 151:506.
23. Vandenbark, A. A., Gill, T. and Offner, H. 1985. A myelin basic protein specific T lymphocyte line which mediates EAE. J. Immunol. 135:223.
24. Linsley, P. S., Brady, W., Grosmaire, L., Aruffo, A., Damle, N. K. and Ledbetter, J. A. 1991. Binding of the B cell activation antigen B7 to CD28 co-stimulates T cell proliferation and interleukin 2 mRNA accumulation. J. Exp. Med. 173:759.
25. + T cells. J. Immunol. 155:45.
26. Thompson, C. B., Lindsten, T., Ledbetter, J, A., Kunkel, S. L., Young, H. A., Emerson, S. G., Leiden, J. M. and June, C. H. 1989 CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines. Proc. Natl Acad. Sci. USA 86:1333.
27. + T cells by B7-transfected melanoma cells. Science 259:368.
28. Lenschow, D. J., Zeng, Y., Thistlethwaite, J. R., Montag, A., Brady, W., Gibson, M. G., Linsley, P. S. and Bluestone, J. A. 1992. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4Ig. Science 257:789.
29. Turka, L. A, Linsley, P. S., Lin, H., Brady, W., Leiden, J. M., Wei, R. Q., Gibson, M. L., Zheng, X. G., Myrdal, S. and Gordon, D. 1992. T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proc. Natl Acad. Sci. USA 89:11102.
30. de Boer, M., Kasran, A., Kwekkeboom, J., Walter, H., Vandenberghe, P. and Ceuppens, J. L. 1993. Ligation of B7 with CD28/CTLA-4 on T cells results in CD40 ligand expression, IL-4 secretion and efficient help for antibody production by B cells. Eur. J. Immunol. 23:3120.
31. June, C. H., Bluestone, J. A., Nadler, L. M. and Thompson, C. B. 1994. The B7 and CD28 receptor families. Immunol. Today 15:321.
32. Pollok, K. E., Kim, Y.-J., Zhou, Z., Hurtado, J., Kim, K. K., Pickard, R. T. and Kwon, B. S. 1993. Inducible T cell antigen 4-1BB; analysis of expression and function. J. Immunol. 150:771.
33. Hurtado, J. C., Kim, Y.-J. and Kwon, B. S. 1997. Signals through 4-1BB are co-stimulatory to previously activated splenic T cells and inhibit activation-induced cell death. J. Immunol. 158:2600.
34. DeBenedette, M. A., Chu, N. R., Pollok, K. E., Hurtado, J., Wade, W. F., Kwon, B. S. and Watts, T. H. 1995, Role of 4-1BB ligand in co-stimulation of T lymphocyte growth and its up-regulation on M12 B lymphomas by cAMP. J. Exp. Med. 181:985.
35. Hurtado, J. C., Kim, S. H., Pollok, K. E., Lee, Z. H. and Kwon, B. S. 1995. Potential role of 4-1BB in T cell activation: comparison with the co-stimulatory molecule CD28. J. Immunol. 155:3360.
36. + T-cell responses, Immunol. Today 17:410.
37. Ranheim, E. A. and Kipps, T. J. 1993. Activated T cells induce expression of B7 on normal or leukemic B cells through a CD40-dependent signal. J. Exp. Med. 177:925.
38. Roy, M., Arrufo, A., Ledbetter, J., Linsley, P., Kehry, M. and Noelle, R. 1995. Studies on the interdependence of gp39 and B7 expression and function during antigen-specific immune responses. Eur. J. Immunol. 25:596.
39. Ding, L., Green, J. M., Thompson, C. B. and Shevach, E. M. 1995. B7/CD28-dependent and -independent induction of CD40 ligand expression. J. Immunol. 155:5124.
40. Shahinian, A., Pfeffer, K., Lee, K. P., Kundig, T. M., Kishihara, K., Wakeham, A., Kawai, K., Ohashi, P. S., Thompson, C. B. and Mak, T. W. 1993. Differential T cell co-stimulatory requirements in CD28-deficient mice. Science 262:609.
41. Green, J. M., Noel, P. J., Sperling, A. I., Walunas, T. L., Gray, G. S., Bluestone, J. A. and Thompson, B. C. 1994. Absence of B7-dependent responses in CD28-deficient mice. Immunity 1:501.
42. Uckun, F. M., Schieven, G. L., Dibirdik, I., Chandan-Langlie, M., Tuel-Ahlgren, L. and Ledbetter, J. A. 1991. Stimulation of protein tyrosine phosphorylation, phosphoinositide turnover, and multiple previously unidentified serine/threonine specific protein kinases by the pan-B-cell receptor CD40/Bp50 at discrete developmental stages of human B cell ontogeny. J. Biol. Chem. 266:17478
43. Melamed, I., Kelleher, C. A., Franklin, R. A., Brodie, C., Hempstead, B., Kaplan, D. and Gelfand, E. W. 1996. Nerve growth factor signal transduction in human B lymphocytes is mediated by gp140trk. Eur. J. Immunol. 26:1985.
44. + T cells with homology to tumor necrosis factor. J. Exp. Med. 180:757.